Hyperfine prices $17.5 million public offering at $1.25 per share

Hyperfine Inc. (NASDAQ: HYPR) priced an underwritten public offering of 14 million shares of Class A common stock at $1.25 per share, the medical technology company announced. The offering is expected to generate gross proceeds of approximately $17.5 million before deducting underwriting discounts and commissions.

The company granted the underwriter a 30-day option to purchase up to 2.1 million additional shares at the public offering price, representing 15% of the total shares being sold. Lake Street Capital Markets LLC serves as the sole book-runner for the offering.

The transaction is expected to close on or about October 17, 2025, subject to customary closing conditions. Hyperfine plans to use the proceeds for working capital and general corporate purposes, including commercial, manufacturing, and research and development activities.

The securities are being offered under an effective shelf registration statement on Form S-3 that was filed with the Securities and Exchange Commission on November 9, 2023, and declared effective on November 22, 2023. A preliminary prospectus supplement was filed with the SEC on October 15, 2025.

Hyperfine develops portable magnetic resonance brain imaging technology, including the Swoop system, which the company describes as the first FDA-cleared, portable, ultra-low-field magnetic resonance brain imaging system.

You May Also Be Interested In

• Singularity Future Technology closes $5M registered direct offering
• enVVeno Medical (NVNO) files $100M mixed shelf
• Sky Century Investment responds to OTC Markets stock promotion inquiry